pubmed-article:20546441 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20546441 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:20546441 | lifeskim:mentions | umls-concept:C0009324 | lld:lifeskim |
pubmed-article:20546441 | lifeskim:mentions | umls-concept:C0085149 | lld:lifeskim |
pubmed-article:20546441 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
pubmed-article:20546441 | lifeskim:mentions | umls-concept:C0666743 | lld:lifeskim |
pubmed-article:20546441 | lifeskim:mentions | umls-concept:C0205269 | lld:lifeskim |
pubmed-article:20546441 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:20546441 | pubmed:dateCreated | 2010-6-15 | lld:pubmed |
pubmed-article:20546441 | pubmed:abstractText | Little is known about the efficacy and safety of infliximab for ulcerative colitis refractory to tacrolimus. The aim of this study was to evaluate the efficacy and safety of infliximab in the induction of remission in ulcerative colitis patients with persistent symptoms despite tacrolimus therapy. | lld:pubmed |
pubmed-article:20546441 | pubmed:language | eng | lld:pubmed |
pubmed-article:20546441 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20546441 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20546441 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20546441 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20546441 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20546441 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20546441 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20546441 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20546441 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20546441 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20546441 | pubmed:month | May | lld:pubmed |
pubmed-article:20546441 | pubmed:issn | 1440-1746 | lld:pubmed |
pubmed-article:20546441 | pubmed:author | pubmed-author:YamamotoShuji... | lld:pubmed |
pubmed-article:20546441 | pubmed:author | pubmed-author:ChibaTsutomuT | lld:pubmed |
pubmed-article:20546441 | pubmed:author | pubmed-author:MasudaSatohir... | lld:pubmed |
pubmed-article:20546441 | pubmed:author | pubmed-author:NakaseHiroshi... | lld:pubmed |
pubmed-article:20546441 | pubmed:author | pubmed-author:InuiKen-ichiK | lld:pubmed |
pubmed-article:20546441 | pubmed:author | pubmed-author:MatsuuraMinor... | lld:pubmed |
pubmed-article:20546441 | pubmed:author | pubmed-author:HonzawaYusuke... | lld:pubmed |
pubmed-article:20546441 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20546441 | pubmed:volume | 25 | lld:pubmed |
pubmed-article:20546441 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20546441 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20546441 | pubmed:pagination | 886-91 | lld:pubmed |
pubmed-article:20546441 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:meshHeading | pubmed-meshheading:20546441... | lld:pubmed |
pubmed-article:20546441 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20546441 | pubmed:articleTitle | Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus. | lld:pubmed |
pubmed-article:20546441 | pubmed:affiliation | Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. | lld:pubmed |
pubmed-article:20546441 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20546441 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |